1. Angiotensin II Receptor Blockers and Risk of Cancer: Cause for Concern? 
Frederic Rahbari-Oskoui, MD, MS 
American Journal of Kidney Diseases 
Volume 57, Issue 1, Pages 7-10 (January 2011)
DOI: /j.ajkd
Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Physiologic process of the renin-angiotensin-aldosterone system (RAAS). Colors represent the following: yellow, players and mediators of the RAAS; green, blockers of the RAAS; blue, pathophysiologic actions; orange, resulting diseases; gray, the bradykinin pathway. Abbreviations: ACE, angiotensin-converting enzyme; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AT1, angiotensin II type 1; FGF, fibroblast growth factor; SNS, sympathetic nervous system; VEGF, vascular endothelial growth factor.
American Journal of Kidney Diseases  , 7-10DOI: ( /j.ajkd )
Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions